Guided Therapeutics (GTHP) Free Cash Flow (2011 - 2026)
Guided Therapeutics (GTHP) posted Free Cash Flow of -$291000.0 for Q4 2025, down 5.05% sequentially from -$277000.0 in Q3 2025, and up 12.35% YoY from -$259013.4 in Q4 2024.
Guided Therapeutics (GTHP) Free Cash Flow (2011 - 2026) Analysis & Trends
Guided Therapeutics has reported Free Cash Flow for 15 years, with the latest figure at -$291000.0 in Q4 2025.
- Quarterly Free Cash Flow rose 12.35% year-over-year to -$291000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.1 million (up 4.56% YoY) and the FY2025 annual result came in at -$1.1 million, up 4.38% from the prior year.
- Free Cash Flow fell to -$291000.0 in Q4 2025 per GTHP's latest filing, from -$277000.0 in the prior quarter.
- Over five years, Free Cash Flow peaked at $128000.0 in Q4 2021 and troughed at -$717000.0 in Q3 2021.
- A 5-year average of -$352450.0 and a median of -$334000.0 in 2023 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2021 and 2022: Free Cash Flow surged 138.67% in 2021, then sank 367.19% in 2022.
- Over 5 years, Free Cash Flow stood at $128000.0 in 2021, then tumbled by 367.19% to -$342000.0 in 2022, then advanced by 1.75% to -$336000.0 in 2023, then increased by 1.19% to -$332000.0 in 2024, then rose by 12.35% to -$291000.0 in 2025.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$291000.0, -$277000.0, and -$169000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.06 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.28 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 585.00 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 184.50 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 68.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 511.44 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 279.60 Mn |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | -319,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -319,000.00 |
| Jun 30, 2026 | -319,000.00 |
| Mar 31, 2026 | -617,000.00 |
| Mar 31, 2026 | -617,000.00 |
| Dec 31, 2025 | -291,000.00 |
| Dec 31, 2025 | -291,000.00 |
| Sep 30, 2025 | -277,000.00 |
| Sep 30, 2025 | -277,000.00 |
| Jun 30, 2025 | -169,000.00 |
| Jun 30, 2025 | -169,000.00 |
| Mar 31, 2025 | -331,000.00 |
| Mar 31, 2025 | -331,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Sep 30, 2024 | -473,000.00 |
| Sep 30, 2024 | -473,000.00 |
| Jun 30, 2024 | -214,000.00 |
| Jun 30, 2024 | -214,000.00 |
| Mar 31, 2024 | -100,000.00 |
| Mar 31, 2024 | -100,000.00 |